Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 22940-22941 [2011-9896]
Download as PDF
22940
Federal Register / Vol. 76, No. 79 / Monday, April 25, 2011 / Notices
applications per year, submitted by
mail. Data, which is extracted from the
form, is necessary to determine
qualifications, and selections, in
accordance with Federal policies.
Dated: April 5, 2011.
Ruben Torres,
Director, HR/EX, Department of State.
[FR Doc. 2011–9952 Filed 4–22–11; 8:45 am]
BILLING CODE 4710–15–P
DEPARTMENT OF TRANSPORTATION
Intelligent Transportation Systems
Program Advisory Committee; Notice
of Meeting
Research and Innovative
Technology Administration, DOT.
ACTION: Notice.
jdjones on DSKHWCL6B1PROD with NOTICES
AGENCY:
This notice announces, pursuant to
Section 10(a)(2) of the Federal Advisory
Committee Act (FACA) (Pub. L. 72–363;
5 U.S.C. app. 2), a Web conference of
the Intelligent Transportation Systems
(ITS) Program Advisory Committee (ITS
PAC). The Web conference will be held
on May 18, 2011, from 1 p.m. to 4 p.m.
The ITS PAC, established under
Section 5305 of Public Law 109–59,
Safe, Accountable, Flexible, Efficient
Transportation Equity Act: A Legacy for
Users, August 10, 2005, and re-chartered
on February 7, 2010, was created to
advise the Secretary of Transportation
on all matters relating to the study,
development, and implementation of
intelligent transportation systems.
Through its sponsor, the ITS Joint
Program Office (JPO), the ITS PAC
makes recommendations to the
Secretary regarding ITS Program needs,
objectives, plans, approaches, content,
and progress.
Following is the Web conference
preliminary agenda: (1) Welcome and
Opening Remarks; (2) Review
Technology Strategy Subcommittee
Findings; (3) Review Standards and
Harmonization Subcommittee Findings;
(4) Review Program Evaluation and
Strategy Subcommittee Findings; and
(5) Summary and Action Item Review.
The Web conference will be available
to the public, but limited conference
lines will be available on a first-come,
first-serve basis. Members of the public
who wish to participate must notify Mr.
Stephen Glasscock, the Committee
Designated Federal Official, at (202)
366–9126 no later than May 11, 2011, at
which time the Web conference URL
and call-in phone number will be
provided. Members of the public who
wish to present oral statements during
the Web conference must request
VerDate Mar<15>2010
15:21 Apr 22, 2011
Jkt 223001
approval from Mr. Glasscock no later
than May 11, 2011.
Questions about the agenda or written
comments may be submitted by U.S.
Mail to: U.S. Department of
Transportation, Research and Innovative
Technology Administration, ITS Joint
Program Office, Attention: Stephen
Glasscock, 1200 New Jersey Avenue,
SE., HOIT, Room E33–415, Washington,
DC 20590 or faxed to (202) 493–2027.
The JPO requests that written comments
be submitted no later than May 11,
2011.
Notice of this Web conference is
provided in accordance with the FACA
and the General Services
Administration regulations (41 CFR part
102–3) covering management of Federal
advisory committees.
Issued in Washington, DC, on the 19th day
of April 2011.
Linda Dodge,
Chief of Staff, ITS Joint Program Office.
[FR Doc. 2011–9954 Filed 4–22–11; 8:45 am]
BILLING CODE 4910–HY–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2011–0025]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt twenty-one
individuals from its rule prohibiting
persons with insulin-treated diabetes
mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
will enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions are effective
April 25, 2011. The exemptions expire
on April 25, 2013.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Director, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Electronic Access
You may see all the comments online
through the Federal Document
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
January 17, 2008 (73 FR 3316), or you
may visit https://edocket.access.gpo.gov/
2008/pdf/E8-785.pdf.
Background
On February 22, 2011, FMCSA
published a notice of receipt of Federal
diabetes exemption applications from
twenty-one individuals and requested
comments from the public (76 FR 9862).
The public comment period closed on
March 24, 2011 and no comments were
received.
FMCSA has evaluated the eligibility
of the twenty-one applicants and
determined that granting the
exemptions to these individuals would
achieve a level of safety equivalent to,
or greater than, the level that would be
achieved by complying with the current
regulation 49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
several risk studies indicated that
drivers with diabetes had a higher rate
of crash involvement than the general
population. The diabetes rule provides
that ‘‘A person is physically qualified to
drive a commercial motor vehicle if that
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control’’ (49 CFR 391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
E:\FR\FM\25APN1.SGM
25APN1
Federal Register / Vol. 76, No. 79 / Monday, April 25, 2011 / Notices
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441)
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777) Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These twenty-one applicants have had
ITDM over a range of 1 to 19 years.
These applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
standard at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the February
22, 2011, Federal Register notice and
they will not be repeated in this notice.
jdjones on DSKHWCL6B1PROD with NOTICES
Discussion of Comment
FMCSA did not receive any
comments in this proceeding.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes standard in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
VerDate Mar<15>2010
15:21 Apr 22, 2011
Jkt 223001
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
Conclusion
Based upon its evaluation of the
twenty-one exemption applications,
FMCSA exempts, Kevin J. Agler, Roger
R. Cabana, Andrew J. Causey, Steven J.
Ceckiewicz, Jamie P. Chapman, Dennis
J. Dallmann, Wade Dawson, Craig A.
Fisher, Ryan D. Gibson, Omar S. Griffin
Jr., George E. Heffernan, Dennis
Hohnerlein, Joshua P. Kramer, Chad M.
Kunkel, Donald L. Kurtz, Jeffery S.
Lomber, Rodney C. McCowan, Jennifer
L. Moran, Kevin J. Van Horn, Jimmy M.
Welch and Michael L. Wintrow from the
ITDM standard in 49 CFR 391.41(b)(3),
subject to the conditions listed under
‘‘Conditions and Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if: (1) The person fails to comply with
the terms and conditions of the
exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
objectives of 49 U.S.C. 31136(e) and
31315. If the exemption is still effective
at the end of the 2-year period, the
person may apply to FMCSA for a
renewal under procedures in effect at
that time.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
22941
Issued on: April 14, 2011.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2011–9896 Filed 4–22–11; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2011–0011]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt sixteen individuals
from its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
April 25, 2011. The exemptions expire
on April 25, 2013.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Director, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
E:\FR\FM\25APN1.SGM
25APN1
Agencies
[Federal Register Volume 76, Number 79 (Monday, April 25, 2011)]
[Notices]
[Pages 22940-22941]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9896]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2011-0025]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt twenty-one individuals
from its rule prohibiting persons with insulin-treated diabetes
mellitus (ITDM) from operating commercial motor vehicles (CMVs) in
interstate commerce. The exemptions will enable these individuals to
operate CMVs in interstate commerce.
DATES: The exemptions are effective April 25, 2011. The exemptions
expire on April 25, 2013.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Director, Medical
Programs, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room W64-224,
Department of Transportation, 1200 New Jersey Avenue, SE., Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
January 17, 2008 (73 FR 3316), or you may visit https://edocket.access.gpo.gov/2008/pdf/E8-785.pdf.
Background
On February 22, 2011, FMCSA published a notice of receipt of
Federal diabetes exemption applications from twenty-one individuals and
requested comments from the public (76 FR 9862). The public comment
period closed on March 24, 2011 and no comments were received.
FMCSA has evaluated the eligibility of the twenty-one applicants
and determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to, or greater than, the level
that would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current standard for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
[[Page 22941]]
operate CMVs is feasible. The September 3, 2003 (68 FR 52441) Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777)
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
These twenty-one applicants have had ITDM over a range of 1 to 19
years. These applicants report no severe hypoglycemic reactions
resulting in loss of consciousness or seizure, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning symptoms, in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the past 5 years.
In each case, an endocrinologist verified that the driver has
demonstrated a willingness to properly monitor and manage his/her
diabetes mellitus, received education related to diabetes management,
and is on a stable insulin regimen. These drivers report no other
disqualifying conditions, including diabetes-related complications.
Each meets the vision standard at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the February 22, 2011, Federal
Register notice and they will not be repeated in this notice.
Discussion of Comment
FMCSA did not receive any comments in this proceeding.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes standard in 49 CFR 391.41(b)(3) is likely
to achieve a level of safety equal to that existing without the
exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
Conclusion
Based upon its evaluation of the twenty-one exemption applications,
FMCSA exempts, Kevin J. Agler, Roger R. Cabana, Andrew J. Causey,
Steven J. Ceckiewicz, Jamie P. Chapman, Dennis J. Dallmann, Wade
Dawson, Craig A. Fisher, Ryan D. Gibson, Omar S. Griffin Jr., George E.
Heffernan, Dennis Hohnerlein, Joshua P. Kramer, Chad M. Kunkel, Donald
L. Kurtz, Jeffery S. Lomber, Rodney C. McCowan, Jennifer L. Moran,
Kevin J. Van Horn, Jimmy M. Welch and Michael L. Wintrow from the ITDM
standard in 49 CFR 391.41(b)(3), subject to the conditions listed under
``Conditions and Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if: (1) The person fails to comply with the terms and
conditions of the exemption; (2) the exemption has resulted in a lower
level of safety than was maintained before it was granted; or (3)
continuation of the exemption would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is
still effective at the end of the 2-year period, the person may apply
to FMCSA for a renewal under procedures in effect at that time.
Issued on: April 14, 2011.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2011-9896 Filed 4-22-11; 8:45 am]
BILLING CODE 4910-EX-P